KR930700502A - 6-아미노옥타히드로인돌리진트리올 유도체 - Google Patents

6-아미노옥타히드로인돌리진트리올 유도체

Info

Publication number
KR930700502A
KR930700502A KR1019920703085A KR920703085A KR930700502A KR 930700502 A KR930700502 A KR 930700502A KR 1019920703085 A KR1019920703085 A KR 1019920703085A KR 920703085 A KR920703085 A KR 920703085A KR 930700502 A KR930700502 A KR 930700502A
Authority
KR
South Korea
Prior art keywords
alkanoyl
indolizintriol
acetamidooctahydro
compound
benzoyl
Prior art date
Application number
KR1019920703085A
Other languages
English (en)
Other versions
KR100195421B1 (ko
Inventor
폴 에스 류
모힌더 에스. 캉
Original Assignee
스티븐 엘. 네스비트
메렐 다우 파마슈티칼스 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스티븐 엘. 네스비트, 메렐 다우 파마슈티칼스 인크. filed Critical 스티븐 엘. 네스비트
Publication of KR930700502A publication Critical patent/KR930700502A/ko
Application granted granted Critical
Publication of KR100195421B1 publication Critical patent/KR100195421B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

내용 없음.

Description

6-아미노옥타히드로인돌리진트리올 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (15)

  1. 하기 일반식의 화합물.
  3. 상기 식중, R은 C1-10알카노일, R´, R″및 R˝′는 독립적으로 수소, C1-10알카노일 또는 벤조일이다.
  4. 제1항에 있어서, [1S-(1α,6β,7α,8β,8αβ)]-6-아세트아미도옥타히드로-1,7,8-인돌리진트리올인 화합물.
  5. 유효량의 하나 일반식의 화합물을 헥소스아미니다제 활성의 억제를 요하는 환자에게 내과적으로 투여하는 것으로 이루어지는 포유 동물의 헥소스아미니다제 활성의 억제 방법.
  7. 상기 식중, R은 C1-10알카노일이고, R´, R″및 R˝′는 독립적으로 수소, C1-10알카노일 또는 벤조일이다.
  8. 제3항에 있어서, [1S-(1α,6β,7α,8β,8αβ)]-6-아세트아미도옥타히드로-1,7,8-인돌리진트리올인 화합물.
  9. 하기식
  11. 의 화합물을 물의 존재하에 식 R-X의 산 할로겐화물 또는 R2O의 산무수물로부터 선택된 아실화제와 반응시켜 대응하는 아미드를 얻고, 추가로 무수 조건하에 동일한 산 할로겐화물 또는 산 무수물과 반응시켜 에스테르를 얻는 것으로 이루어진 하기 일반식의 화합물의 제조방법.
  13. 상기 식중, R은 C1-10알카노일, R´, R″및 R˝´는 독립적으로 수소, C1-10알카노일 또는 벤조일이고, X는 염소 또는 브롬이다.
  14. 제5항에 있어서, [1S-(1α,6β,7α,8β,8αβ)]-6-아세트아미도옥타히드로-1,7,8-인돌리진트리올을 물의 존재하에 아세트산 무수물과 반응시키는 것으로 이루지는 [1S-(1α,6β,7α,8β,8αβ)]-6-아세트아미도옥타히드로-1,7,8-인돌리진트리올의 제조방법.
  15. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920703085A 1990-06-04 1991-05-08 6-아미노옥타히드로인돌리진트리올유도체 KR100195421B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/532,522 US5079254A (en) 1990-06-04 1990-06-04 Derivatives of 6-aminooctahydroindolizinetriol
US532,522 1990-06-04
PCT/US1991/003179 WO1991018598A1 (en) 1990-06-04 1991-05-08 Derivatives of 6-aminooctahydroindolizinetriol

Publications (2)

Publication Number Publication Date
KR930700502A true KR930700502A (ko) 1993-03-15
KR100195421B1 KR100195421B1 (ko) 1999-06-15

Family

ID=24122149

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920703085A KR100195421B1 (ko) 1990-06-04 1991-05-08 6-아미노옥타히드로인돌리진트리올유도체

Country Status (15)

Country Link
US (1) US5079254A (ko)
EP (1) EP0532530B1 (ko)
JP (1) JP3019265B2 (ko)
KR (1) KR100195421B1 (ko)
AT (1) ATE155685T1 (ko)
AU (1) AU641771B2 (ko)
CA (1) CA2082820C (ko)
DE (1) DE69126978T2 (ko)
DK (1) DK0532530T3 (ko)
ES (1) ES2106080T3 (ko)
FI (1) FI97226C (ko)
GR (1) GR3025044T3 (ko)
HU (1) HU212579B (ko)
NO (1) NO300686B1 (ko)
WO (1) WO1991018598A1 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013538A1 (en) * 1993-11-12 1995-05-18 Operon Technologies, Inc. Methods of producing and screening complex chemical libraries
WO1995019359A1 (en) * 1994-01-12 1995-07-20 Massachusetts Institute Of Technology Process for making xanthene or cubane based compounds, and protease inhibitors
EP1633356A1 (en) * 2003-05-22 2006-03-15 The Hospital for Sick Children Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity
WO2005072268A2 (en) * 2004-01-20 2005-08-11 Optimer Pharmaceuticals, Inc. Treatment of degeneraative cartilage conditions in a mammal with glycosidase inhibitors
KR100858512B1 (ko) 2007-03-29 2008-09-12 포항공과대학교 산학협력단 헥소스아미니데이즈 활성 저해 방법
AU2009276222B2 (en) * 2008-08-01 2015-03-05 Simon Fraser University Selective glycosidase inhibitors and uses thereof
PT2655388T (pt) 2010-12-23 2016-09-06 Merck Sharp & Dohme Inibidores de glicosidase seletivos e as suas utilizações
EP2691407B1 (en) 2011-03-31 2017-02-22 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
WO2013000086A1 (en) 2011-06-27 2013-01-03 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
US9809537B2 (en) 2012-08-31 2017-11-07 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof
WO2014032185A1 (en) 2012-08-31 2014-03-06 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof
RU2672873C2 (ru) 2012-10-31 2018-11-20 Алектос Терапьютикс Инк. Ингибиторы гликозидаз и их применения

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5973519A (ja) * 1982-09-17 1984-04-25 Fujisawa Pharmaceut Co Ltd スワインソニンの製造法およびそれを含む免疫調整剤
GB8429810D0 (en) * 1984-11-26 1985-01-03 Fujisawa Pharmaceutical Co Indolizidine derivatives
JPS61277685A (ja) * 1985-05-31 1986-12-08 Fujisawa Pharmaceut Co Ltd 新規インドリジジン誘導体、その製造法およびそれを含有する組成物
DE3620645A1 (de) * 1985-12-20 1987-07-02 Bayer Ag 3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
JPH01129182A (ja) * 1987-11-16 1989-05-22 Tokyo Keiki Co Ltd 波動伝搬時間測定装置
JPH01277685A (ja) * 1988-04-28 1989-11-08 Hitachi Ltd ピストンポンプ

Also Published As

Publication number Publication date
FI925260A (fi) 1992-11-19
FI97226C (fi) 1996-11-11
NO300686B1 (no) 1997-07-07
DE69126978T2 (de) 1997-11-27
FI97226B (fi) 1996-07-31
DE69126978D1 (de) 1997-08-28
ES2106080T3 (es) 1997-11-01
ATE155685T1 (de) 1997-08-15
DK0532530T3 (da) 1997-08-25
GR3025044T3 (en) 1998-01-30
FI925260A0 (fi) 1992-11-19
AU7874391A (en) 1991-12-31
EP0532530A1 (en) 1993-03-24
HU212579B (en) 1996-08-29
NO924670D0 (no) 1992-12-03
HUT62585A (en) 1993-05-28
CA2082820A1 (en) 1991-12-05
EP0532530A4 (en) 1993-05-26
HU9203829D0 (en) 1993-03-29
CA2082820C (en) 2002-01-22
WO1991018598A1 (en) 1991-12-12
NO924670L (no) 1992-12-03
KR100195421B1 (ko) 1999-06-15
US5079254A (en) 1992-01-07
JPH05507474A (ja) 1993-10-28
AU641771B2 (en) 1993-09-30
JP3019265B2 (ja) 2000-03-13
EP0532530B1 (en) 1997-07-23

Similar Documents

Publication Publication Date Title
DK504183A (da) Guaninderivater og fremgangsmaade til fremstilling deraf
KR900016189A (ko) 3-치환된-2-옥스인돌 유도체
KR940007022A (ko) 피패리딘 유도체, 이것의 제법 및 치료에 있어서 이것의 이용
KR960000230A (ko) 간담즙성 질병 치료제
KR930700502A (ko) 6-아미노옥타히드로인돌리진트리올 유도체
IT1152287B (it) Pirrolidin-derivati
KR950000663A (ko) 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
KR970707108A (ko) 항염증제로 유용한, 복소환부를 갖는 디-t-부틸페놀 화합물(DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
KR950702831A (ko) 심장 보호제(cardio-protective agent)
KR950011462A (ko) 호르몬 활성이 저하된 에스트라디올 유도체-알킬화제 결합체, 그의 제조방법, 그의 제조에 유용한 화합물, 및 상기 결합체 또는 에스트라디올 유도체를 함유하는 성장억제조성물
KR900016135A (ko) 피부 및 점막-상피의 질환 치료용 4-퀴놀린 카복실산 유도체
KR890014480A (ko) 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
KR890000482A (ko) (8β)-1-알킬-6-(치환된) 에르 골린의 시클로알킬아미드
EA199800155A1 (ru) Новое соединение
KR900001715A (ko) Bu-3608 유도체
ATE73449T1 (de) 2-piperazinyl-2-oxo-aethylensubstituierte flavonoid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen.
KR880012634A (ko) C_17-20리아제 억제제로서 유용한 17β-(사이클로프로필옥시)안드로스트-5-엔-3β-올 및 관련 화합물
KR880009926A (ko) 알킬멜라토닌
KR890002103A (ko) 피페리딘 유도체, 그의제법 및 도르지발 38
KR920012008A (ko) 페닐알킬아미노알킬 화합물과 이들의 제법 및 이 화합물들을 포함하는 약물
KR850008491A (ko) 신규 세팔로스포린의 제조방법
KR850002477A (ko) 4-(3-알키닐옥시-2-하이드록시-프로필)-피퍼라진-1-일-n-페닐-아세트아미드 유도체의 제조방법
KR930702339A (ko) 에폭시숙시남산 유도체
KR920701232A (ko) 신규 9α-히드록시-3-옥소-4,24(25)-스티그마스타디엔-26-산 유도체, 이의 제조법 및 이를 함유하는 약학 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030204

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee